Seeking Adults and Children With MDS or MDS/MPN
Dr. El Jurdi and her team at the National Institutes of Health (NIH) are seeking adults and children aged 12 and older with myelodysplastic syndrome (MDS) or myelodysplastic/myeloproliferative neoplasm (MDS/MPN) for a clinical research study. This clinical research study is evaluating the safety and effectiveness of an investigational drug, pacritinib. Parental consent is required for minors.
Clinical Evaluation of Pediatric and Adults with Myelodysplastic Syndromes (MDS)
Myelodysplastic syndromes (MDS) are disorders caused by abnormal blood cell production, potentially leading to low cell counts and increased susceptibility to clotting and infections. Past research suggests that inflammation may trigger these abnormalities, and this study seeks to further understand and improve treatment strategies for MDS by investigating the role of inflammation in bone marrow cell development.